Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Biotech
Biotech
AI
U.K. startup CellVoyant debuts AI platform that could radically reduce the cost of cell-based therapies such as CAR-T immunotherapy for cancer
By
Jeremy Kahn
December 18, 2025
Commentary
China is winning the biotech race. Patent reform is how we catch up
By
Gary Locke
December 12, 2025
AI
Longevity science is on the cusp of major breakthroughs thanks to AI, but significant ‘data gaps’ need to be filled, expert says
By
Alexei Oreskovic
October 30, 2025
Commentary
The AI wave: For a maximalist, things couldn’t be better
By
Bipul Sinha
October 27, 2025
AI
Jeff Bezos agrees with OpenAI’s Sam Altman: We’re in an AI bubble. But Amazon’s founder says the benefits will be ‘gigantic’
By
Nino Paoli
October 4, 2025
Newsletters
xAI sues Apple and OpenAI
By
Andrew Nusca
August 26, 2025
AI
OpenAI warns that its new ChatGPT Agent has the ability to aid dangerous bioweapon development
By
Beatrice Nolan
July 18, 2025
Commentary
Howard Dean: Slashing public health funding is a national security disaster in the making
By
Howard Dean
June 10, 2025
Tech
‘This is not Theranos 2.0′: Elizabeth Holmes’ partner is the CEO behind new blood-testing startup
By
Beatrice Nolan
May 12, 2025
Commentary
Why federal funding for life sciences—now being slashed—is a strategic necessity for America
By
Tiffany Wilson
April 17, 2025
Tech
Exclusive: Biotech startup Profluent says it has discovered AI ‘scaling laws’ for AI models used in protein design
By
Jeremy Kahn
April 16, 2025
Features
Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market
By
Erika Fry
April 3, 2025
Tech
As a kid, she raised money to cure cystic fibrosis. Now she’s the CEO of a $2.6 billion genetic testing company
By
Andrew Nusca
March 31, 2025
Health
23andMe users are being urged to delete their data. Here’s how to do it
By
Alexa Mikhail
and
Beth Greenfield
March 24, 2025
Tech
23andMe users told to consider deleting their data by California attorney general as the company files for bankruptcy
By
Beatrice Nolan
March 24, 2025
Most Popular
Economy
The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
By
Nick Lichtenberg
AI
'Robots are going to be amongst us': Qualcomm exec says buckle up for the next 5 years. Your car is going to be the...
By
Nino Paoli
C-Suite
Red Lobster CEO Damola Adamolekun says the key to being a better leader is being a better person: ‘Leadership is...
By
Sydney Lake